Gujarat Alkalies and Chemicals Ltd. Financial Results and Expansion Plans

Gujarat Alkalies and Chemicals Ltd. (GACL) announced its audited financial results for the year ended March 31, 2026. The company reported standalone revenue from operations of ₹4,358.08 crore, a 7.0% increase from ₹4,072.91 crore in the previous year. Standalone net profit surged by 31.7% to ₹20.84 crore from ₹15.82 crore year-on-year.

Reader Takeaway: Strong standalone profit growth; JV losses impact consolidated results.

What just happened

GACL's Board of Directors recommended a final dividend of ₹17.70 per equity share (177%) for FY26, subject to shareholder approval. The Board also approved the setup of a new 5000 TPA High Purity Grade Hydrogen Peroxide plant at Dahej, Gujarat, with an estimated investment of ₹67 crore. This plant is expected to be operational within 18 months and contribute approximately ₹42 crore to annual sales revenue.

Why this matters

The dividend payout directly benefits shareholders, providing a tangible return on investment. The new Hydrogen Peroxide plant signifies GACL's strategic move into high-purity chemicals, targeting lucrative sectors like semiconductor fabrication and solar cell manufacturing. This expansion aims to tap into emerging, high-growth markets, diversifying the company's revenue streams.

The backstory

For FY26, GACL reported a standalone profit of ₹20.84 crore, a significant improvement from ₹15.82 crore in the prior year. However, on a consolidated basis, the company posted a loss of ₹2.41 crore, a notable improvement from a loss of ₹65.12 crore in the previous year. This divergence is attributed to losses incurred in its joint ventures and associates.

What changes now

Shareholders can anticipate a dividend payout if approved. The strategic investment in the Hydrogen Peroxide plant indicates a future focus on higher-margin, specialized chemical products. The company is positioning itself for growth in advanced technology sectors.

Risks to watch

A key concern remains the consolidated loss, driven by a loss of ₹38.69 crore in the GACL-NALCO Alkalies & Chemicals Pvt Ltd joint venture during the year, adding to accumulated losses of ₹633.31 crore. These ongoing JV losses continue to weigh on the company's overall financial performance and require careful monitoring.

Peer comparison

While specific peer financial comparisons are not provided in the filing, GACL operates in the chemical manufacturing sector. Companies in this sector often focus on capacity expansion and diversification into specialty chemicals to improve margins and market positioning.

Context metrics (time-bound)

• Standalone Revenue (FY26): ₹4,358.08 crore (up 7.0% YoY)
• Standalone Net Profit (FY26): ₹20.84 crore (up 31.7% YoY)
• Consolidated Net Profit (FY26): ₹-2.41 crore (improvement from ₹-65.12 crore YoY)
• Hydrogen Peroxide Plant Capex: ₹67 crore
• Expected Revenue from new plant: ₹42 crore annually
• Dividend: ₹17.70 per share (177%)

What to track next

Investors should monitor the progress of the new Hydrogen Peroxide plant construction and its timely commissioning. Tracking the financial performance of joint ventures, particularly the GACL-NALCO JV, will be crucial for assessing the company's consolidated profitability. Further updates on market demand for high-purity hydrogen peroxide will also be important.